vs

Side-by-side financial comparison of DOMO, INC. (DOMO) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

DOMO, INC. is the larger business by last-quarter revenue ($79.4M vs $57.3M, roughly 1.4× RHYTHM PHARMACEUTICALS, INC.). DOMO, INC. runs the higher net margin — -13.1% vs -83.0%, a 69.9% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -0.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -0.5%).

Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

DOMO vs RYTM — Head-to-Head

Bigger by revenue
DOMO
DOMO
1.4× larger
DOMO
$79.4M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+37.3% gap
RYTM
36.9%
-0.5%
DOMO
Higher net margin
DOMO
DOMO
69.9% more per $
DOMO
-13.1%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
-0.5%
DOMO

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DOMO
DOMO
RYTM
RYTM
Revenue
$79.4M
$57.3M
Net Profit
$-10.4M
$-47.5M
Gross Margin
74.2%
91.6%
Operating Margin
-8.7%
-82.2%
Net Margin
-13.1%
-83.0%
Revenue YoY
-0.5%
36.9%
Net Profit YoY
44.6%
-9.6%
EPS (diluted)
$-0.25
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOMO
DOMO
RYTM
RYTM
Q4 25
$79.4M
$57.3M
Q3 25
$79.7M
$51.3M
Q2 25
$80.1M
$48.5M
Q1 25
$78.8M
$32.7M
Q4 24
$79.8M
$41.8M
Q3 24
$78.4M
$33.3M
Q2 24
$80.1M
$29.1M
Q1 24
$80.2M
$26.0M
Net Profit
DOMO
DOMO
RYTM
RYTM
Q4 25
$-10.4M
$-47.5M
Q3 25
$-22.9M
$-52.9M
Q2 25
$-18.1M
$-46.6M
Q1 25
$-17.7M
$-49.5M
Q4 24
$-18.8M
$-43.3M
Q3 24
$-19.5M
$-43.6M
Q2 24
$-26.0M
$-32.3M
Q1 24
$-18.7M
$-141.4M
Gross Margin
DOMO
DOMO
RYTM
RYTM
Q4 25
74.2%
91.6%
Q3 25
74.8%
89.3%
Q2 25
74.2%
88.6%
Q1 25
74.4%
88.8%
Q4 24
75.0%
90.9%
Q3 24
74.3%
88.5%
Q2 24
74.1%
89.9%
Q1 24
76.3%
89.2%
Operating Margin
DOMO
DOMO
RYTM
RYTM
Q4 25
-8.7%
-82.2%
Q3 25
-9.1%
-102.6%
Q2 25
-17.9%
-93.4%
Q1 25
-15.6%
-143.7%
Q4 24
-13.9%
-98.6%
Q3 24
-18.5%
-132.0%
Q2 24
-26.8%
-139.2%
Q1 24
-16.6%
-538.7%
Net Margin
DOMO
DOMO
RYTM
RYTM
Q4 25
-13.1%
-83.0%
Q3 25
-28.8%
-103.1%
Q2 25
-22.5%
-96.1%
Q1 25
-22.4%
-151.4%
Q4 24
-23.5%
-103.6%
Q3 24
-24.9%
-131.2%
Q2 24
-32.5%
-110.9%
Q1 24
-23.3%
-544.4%
EPS (diluted)
DOMO
DOMO
RYTM
RYTM
Q4 25
$-0.25
$-0.73
Q3 25
$-0.56
$-0.82
Q2 25
$-0.45
$-0.75
Q1 25
$-0.45
$-0.81
Q4 24
$-0.48
$-0.71
Q3 24
$-0.51
$-0.73
Q2 24
$-0.69
$-0.55
Q1 24
$-0.51
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOMO
DOMO
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$388.9M
Total DebtLower is stronger
$124.2M
Stockholders' EquityBook value
$-191.9M
$139.1M
Total Assets
$201.6M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOMO
DOMO
RYTM
RYTM
Q4 25
$388.9M
Q3 25
$416.1M
Q2 25
$47.2M
$291.0M
Q1 25
$45.3M
$314.5M
Q4 24
$320.6M
Q3 24
$298.4M
Q2 24
$61.2M
$319.1M
Q1 24
$60.9M
$201.2M
Total Debt
DOMO
DOMO
RYTM
RYTM
Q4 25
$124.2M
Q3 25
$121.9M
Q2 25
$119.7M
Q1 25
$117.7M
Q4 24
$115.6M
Q3 24
$115.2M
Q2 24
$114.1M
Q1 24
$113.5M
Stockholders' Equity
DOMO
DOMO
RYTM
RYTM
Q4 25
$-191.9M
$139.1M
Q3 25
$-191.5M
$148.8M
Q2 25
$-178.7M
$-11.9M
Q1 25
$-177.2M
$18.9M
Q4 24
$-171.2M
$21.7M
Q3 24
$-166.4M
$11.2M
Q2 24
$-163.5M
$39.3M
Q1 24
$-153.5M
$61.6M
Total Assets
DOMO
DOMO
RYTM
RYTM
Q4 25
$201.6M
$480.2M
Q3 25
$195.7M
$506.9M
Q2 25
$189.7M
$372.7M
Q1 25
$214.3M
$386.7M
Q4 24
$190.2M
$392.3M
Q3 24
$197.8M
$363.6M
Q2 24
$204.4M
$381.8M
Q1 24
$225.7M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOMO
DOMO
RYTM
RYTM
Operating Cash FlowLast quarter
$3.4M
$-25.4M
Free Cash FlowOCF − Capex
$1.1M
FCF MarginFCF / Revenue
1.4%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOMO
DOMO
RYTM
RYTM
Q4 25
$3.4M
$-25.4M
Q3 25
$3.4M
$-26.6M
Q2 25
$4.0M
$-23.3M
Q1 25
$8.9M
$-40.4M
Q4 24
$-13.7M
$-18.8M
Q3 24
$-6.2M
$-25.2M
Q2 24
$1.9M
$-29.1M
Q1 24
$5.4M
$-40.7M
Free Cash Flow
DOMO
DOMO
RYTM
RYTM
Q4 25
$1.1M
Q3 25
$1.0M
Q2 25
$1.0M
Q1 25
$6.7M
Q4 24
$-16.2M
Q3 24
$-8.4M
Q2 24
$-625.0K
Q1 24
$2.9M
FCF Margin
DOMO
DOMO
RYTM
RYTM
Q4 25
1.4%
Q3 25
1.3%
Q2 25
1.3%
Q1 25
8.5%
Q4 24
-20.3%
Q3 24
-10.7%
Q2 24
-0.8%
Q1 24
3.6%
Capex Intensity
DOMO
DOMO
RYTM
RYTM
Q4 25
2.9%
Q3 25
2.9%
Q2 25
3.7%
Q1 25
2.8%
Q4 24
3.2%
Q3 24
2.8%
Q2 24
3.2%
Q1 24
3.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOMO
DOMO

Subscription$71.9M91%
Professional Servicesand Other$7.5M9%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons